- Home
- XENE vs AZZ Comparison
XENE vs AZZ Comparison
Compare XENE & AZZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | XENE | AZZ |
|---|---|---|
| Founded | 1996 | 1956 |
| Country | Canada | United States |
| Employees | 370 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Specialties |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.3B | 4.3B |
| IPO Year | 2014 | 1994 |
Fundamental Metrics
Financial Performance| Metric | XENE | AZZ |
|---|---|---|
| Price | $54.29 | $137.27 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 11 | 5 |
| Target Price | $68.55 | ★ $141.80 |
| AVG Volume (30 Days) | ★ 803.9K | 171.6K |
| Earning Date | 05-08-2026 | 04-22-2026 |
| Dividend Yield | N/A | ★ 0.58% |
| EPS Growth | N/A | ★ 486.59 |
| EPS | N/A | ★ 10.50 |
| Revenue | $311,000.00 | ★ $1,061,817,000.00 |
| Revenue This Year | N/A | $7.03 |
| Revenue Next Year | $2,496.48 | $4.25 |
| P/E Ratio | ★ N/A | $13.10 |
| Revenue Growth | N/A | ★ 14.53 |
| 52 Week Low | $28.19 | $86.67 |
| 52 Week High | $62.91 | $151.67 |
Technical Indicators
Market Signals| Indicator | XENE | AZZ |
|---|---|---|
| Relative Strength Index (RSI) | 43.81 | 45.85 |
| Support Level | $52.92 | $131.60 |
| Resistance Level | $59.43 | $140.60 |
| Average True Range (ATR) | 1.67 | 4.24 |
| MACD | -0.31 | -1.57 |
| Stochastic Oscillator | 23.98 | 17.71 |
Price Performance
Historical ComparisonAbout XENE Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.
About AZZ AZZ Inc.
AZZ Inc is a provider of galvanizing and coil coating solutions to a broad range of end markets in North America. The company's operating segment consists of AZZ Metal Coatings, AZZ Precoat Metals, and AZZ Infrastructure Solutions. The company generates the majority of its revenue from the Precoat Metals segment, which provides coil coating application of protective and decorative coatings and related value-added downstream processing for steel and aluminum coils. Geographically, the company operates in the United States and Canada.